National recall issued for common pain medication over dosage issue – CTV
May 04, 2025
Health Canada has published a nationwide recall alert for one lot of JAMP-Pregabalin 50 mg bottles, because some bottles may contain 150 mg capsules.
JAMP Pharma Corp., the manufacturer, is recalling the product (Lot number 2305012747, DIN 02435985, expiry date: 2026-08) since it could lead to patients receiving a higher than prescribed dose of the medication, which could result in an overdose and pose “serious, potentially fatal health risks,” the recall and safety alert says.
Health Canada says JAMP-Pregabalin is prescribed to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injuries in adults, as well as a pain treatment for fibromyalgia.
“Taking too much pregabalin or suddenly increasing the dose could potentially lead to an overdose, which can be life-threatening,” the recall reads.
Pregabalin overdose may cause sudden mood changes, sleepiness, confusion, depression, agitation, restlessness and seizures. If taken while taking any drugs acting on the central nervous system, including opioids, it can lead to heart electrical problems, seizures and even death, warns the notice.
Anyone experiencing symptoms of an overdose is advised to seek immediate medical attention.
